Literature DB >> 7391344

Drug use in an intensive care unit and its relations to survival.

R A Campos, F X Herraez, R J Marcos, J G Amer, R C Porcar, P I Lucia.   

Abstract

Admissions during the first 6 months of 1978, 427 in all, have been reviewed in relation to their pharmacological treatment and mortality rates. They have been divided into five groups according to their diagnoses, and for mortality evaluation. Tagge's prognostic classification was applied. Length of stay, number of drugs used in each patient, and cost of pharmacological therapy, do not have a significant relation to survival. Conclusions stress the great importance of determining uniform admission criteria to evaluate the degree of effort in money, personnel and hospital support to be spent on these kind of patients.

Entities:  

Mesh:

Year:  1980        PMID: 7391344     DOI: 10.1007/bf01757298

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

1.  Drug utilization in a newborn intensive care unit.

Authors:  J V Aranda; S Cohen; A H Neims
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

2.  The inverse relationship between cost and survival.

Authors:  J M Civetta
Journal:  J Surg Res       Date:  1973-03       Impact factor: 2.192

3.  Medical intensive care in the teaching hospital: costs versus benefits. The need for assessment.

Authors:  P F Griner
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

4.  Results and costs of intensive care.

Authors:  D J Cullen
Journal:  Anesthesiology       Date:  1977-08       Impact factor: 7.892

5.  [Economic and prognostic considerations in resuscitation].

Authors:  J R Le Gall
Journal:  Rev Prat       Date:  1978-01-01

6.  Cimetidine (Tagamet): update on adverse effects.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1978-09-08       Impact factor: 1.909

7.  Drug utilization in a general intensive care unit.

Authors:  N Buchanan; R D Cane
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

  7 in total
  6 in total

1.  Clearance of ceftriaxone in critical care patients with acute renal failure.

Authors:  G Heinemeyer; J Link; W Weber; V Meschede; I Roots
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Paralysis for ventilated patients? Yes or no?

Authors:  S M Willatts
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

Review 3.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

4.  Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital.

Authors:  G Heinemeyer; H J Gramm; W Simgen; R Dennhardt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction.

Authors:  G Heinemeyer; H J Gramm; I Roots; R Dennhardt; W Simgen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Clinical pharmacological and therapeutic considerations in general intensive care. A review.

Authors:  M L Farina; M Bonati; G Iapichino; A Pesenti; F Procaccio; L Boselli; M Langer; A Graziina; G Tognoni
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.